Testing the Addition of Nivolumab to Chemotherapy in Treatment of Soft Tissue Sarcoma

NCT04339738 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

90

Enrollment

NIH

Sponsor class

Conditions

Skin Angiosarcoma
Skin Radiation-Related Angiosarcoma
Visceral Angiosarcoma

Interventions

PROCEDURE: Biospecimen Collection
DRUG: Cabozantinib S-malate
PROCEDURE: Computed Tomography
PROCEDURE: FDG-Positron Emission Tomography
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Nivolumab
DRUG: Paclitaxel
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration

Sponsor

National Cancer Institute (NCI)